Convergence of immunodiagnostic and molecular tests will help meet demand in developed countries,says Frost & Sullivan
Unique disease outbreaks across the globe are escalating the demand for screening and spurring the infectious disease diagnostic market. The market will continue to develop as unmet technological needs lead to the creation of faster, more capable platforms. Molecular diagnostics is growing the fastest among the infectious disease market segments, clocking a compound annual growth of 15.30 percent. Although these...
Professor Colin Garner, Chief Executive of Antibiotic Research UK (ANTRUK), the world’s first charity to tackle the impending health disaster of antibiotic resistance, welcomed the publication of the first report by the O’Neill Commission on antibiotic resistance.
Set up by the Prime Minister, Jim O’Neill and his colleagues were tasked with looking at the economic and societal costs of antibiotic resistance. The figures published today by the O’Neill commission make sobering reading. They estimate by 2050 there will be 10 million deaths a year from antibiotic resistant infections at a cost of up to $100 trillion. Professor Garner said ‘the O’Neill commission’s first report highlights just how...
DELMIC develops and manufactures products which are focused on high performance, user friendly, integrated microscopy solutions.
Users of the SPARC technology at Chalmers University of Technology in Gothenburg, Sweden are applying cathodoluminescence measurements to study the properties of nanophotonic devices. Dr Ruggero Verre is a post-doctoral researcher in the Department of Applied Physics - Division of Bionanophotonics at the Chalmers University of Technology in Gothenburg in southern Sweden. His work in the group headed by...
STEMMER IMAGING is one of seven partners from England, Spain and Germany comprising the MICROLEAN project to develop a retrofitable automated microtome system for histology.
This 24-month project, funded from the European Union Seventh Framework Programme (FP7-SME-2013), will incorporate a contactless sample transportation system for histology. Histology, the microscopic examination of cell tissue samples, is an essential component in the early detection of diseases such as cancer. Total pathology services, of which histology is an important part, costs the UK’s NHS an estimated £2.5 billion...
Join us on the 23rd & 24th February in Manchester Central Convention Complex to celebrate the success of the 10th Annual Biomarkers Congress, the leading Biomarkers congress in Europe.
Expecting to bring together over 250 senior level delegates representing leading biotech companies, global pharma organisations and internationally renowned academic institutions. The congress features 6 interactive streams:
Leaks at gas chromatography (GC) column connections are a common source of frustration and wasted time in laboratories.
Time is often spent manually tightening connections between columns using a handheld tool – time which could otherwise be spent analyzing results or running more investigations. Preventing GC leaks has become a priority for researchers looking to save time and money while achieving high quality results. GC column connections leak because capillary column ferrules made of graphite polyimide blends loosen after...
The Pittsburgh Conference on Analytical Chemistry and Applied Spectroscopy, a Pennsylvania non-profit corporation, is proud to announce its 2015 Pittsburgh Conference Memorial National College Grant (PCMNCG) recipients.
The maximum funding available this year for each grant is $10,000 and is awarded to the science departments of colleges with less than 5,000 full-time students for the purchase of scientific equipment, audio-visual or other teaching aids, and/or library materials for use in the teaching of science at the undergraduate level. This year’s awardees are as follows...
A host of dynamic and influential scientists, lecturers and clinicians in the pathology field were amongst over 115 delegates who convened in London recently to present important scientific findings for ‘Next Generation Diagnostics’, the subject of the fourth Innovation Academy Scientific Symposium organised by Viapath.
Held in the auspicious setting of The Grocers’ Hall in the City of London on 5 December 2014, the day-long free symposium was opened by Dr Dominic Harrington, Scientific Director at Viapath, who spoke of the unprecedented opportunity that the Innovation Academy offered to the profession to share ideas around the founding principles of Innovation, Quality and Staff Development and ultimately improve the lives of patients...
To make sure you get the right system make sure you’ve considered these questions...
Freeze dryers can be complicated pieces of specialised equipment, with controlled heating, cooling and vacuum interacting with each other to provide the best drying conditions. They are used for many different types of product and there are therefore a variety of different types of system with hundreds of options to enable them to suit the requirements of different industries and applications.
Point-of-care device set to overcome many of today’s Ebola diagnosis challenges
Product design and development firm Cambridge Consultants is working with non-profit enterprise Diagnostics For All to develop a low-cost point-of-care device for testing patients for the Ebola virus. The project is being funded with a $1m challenge grant from Massachusetts Life Sciences Center, which supports innovation-driven economic development initiatives. The goal of the project is to develop a device – within months rather than...
Alon Vaisman, Product Development Manager for Process Systems at Malvern Instruments, will speak about two quite different analytical techniques and their applications as part of the ‘Particle Characterization’ session at this year’s IFPAC® (International Forum on Process Analytical Technology and Quality by Design) Annual Meeting.
In separate presentations he will discuss the ‘Applications of Dynamic Light Scattering as PAT for on-line nano-particle characterization’ and ‘In-situ monitoring of high shear and fluid bed processing using spatial filter velocimetry’. Both address areas of growing emphasis in pharmaceutical production. The continuing importance of large molecule based therapeutics, and the drive to reduce the particulate size of small molecule APIs, is bringing new challenges for...
AMSBIO has announced several products suitable for the development of an ELISA detection assay for the Ebola virus.
The new products comprise 3 different monoclonal antibodies to the Ebola virus and 2 recombinant proteins (from the Sudan and Zaire strains) suitable for use in producing an optimised ELISA test kit for Ebola. An antigen-capture enzyme-linked immunosorbant assay (ELISA) test for Ebola offers the possibility of diagnosis within the first few days after symptoms begin. Ebola, also known as Ebola hemorrhagic fever, is a disease that typically...
Integrated DNA Technologies (IDT), and Ubiquitome today announced a partnership to develop the Ubiquitome Freedom4 Real-Time RT-PCR Ebola Virus Assay for easy use in the field.
This rapid test is designed to be run on Ubiquitome’s hand-held, battery powered real-time PCR device, the Freedom4. IDT, a market leader in the manufacture of GMP quality products for use in molecular diagnostic tests, is leveraging its PrimeTime qPCR Assay platform to develop an assay that will provide accurate and consistent test results for Ebola virus disease. Fitting in the palm of a hand, Ubiquitome’s Freedom4...
A new company, Alizé Pharma III SAS, has been set up to develop this project
Dr. David Clemmons, co-inventor of the technology and a highly reputable key opinion leader in endocrinology and metabolism, will collaborate on the drug optimization and development programs. Alizé Pharma III SAS, an Alizé Pharma group company specialized in the development of biopharmaceuticals to treat metabolic disorders and rare diseases, today announces that it has acquired exclusive worldwide rights to...
The Clinical and Laboratory Standards Institute (CLSI) has released an updated document, Nongynecological Cytology Specimens: Preexaminiation, Examination, and Postexamination Processes; Approved Guideline—Second Edition (GP23-A2).
This document provides recommendations for cytology laboratories to use in developing preexamination, examination, and postexamination processes and procedures for nongynecological cytology specimen management. All specimens sent for nongynecological cytology evaluation should be collected and prepared using techniques that produce slide preparations that improve patients’ medical care by enhancing diagnostic accuracy in a cost-effective manner. This edition...
An automated dynamic light scattering system from Malvern Instruments has become established as an essential part of the analytical toolkit used by SARomics Biostructures AB, a leading provider of protein 3D structure determination and structure-based drug design services.
The Zetasizer APS automated plate sampling system is supporting the systematic study of the aggregation behavior of proteins, a fundamental component of the services provided by SARomics Biostructures. The company, which is based in Lund, Sweden within the biotech cluster of the Medicon Valley, is a research-intensive organization with clients around the world. The Zetasizer APS is a robust, simple-to-operate system that uses laser light scattering to determine a number of parameters associated...
Norovirus season is upon us and Bioquell has issued tools to help combat the spread.
The two documents are now available to download from the company’s website. The first one is an application sheet which gives useful information as per how to arrest this annual outbreak. The second one is an educational infographic with facts about the virus, its impact and the ways to tackle it. Norovirus, or the diarrhoea and vomiting (D&V) bug, is a highly contagious winter scourge for which there is no treatment...
A novel Parkinson's vaccine will now be tested in a clinical Phase I trial in Austria by an EU-funded consortium.
The vaccine was developed by the Austrian biotech company AFFiRiS AG and targets a protein called alpha-Synuclein. The protein plays a key role in the onset and progression of Parkinson's as well as multiple system atrophy (MSA), an orphan disease. This vaccine has the potential to modify disease progression, rather than only symptomatic improvements available with current treatment strategies. The start of the...
Today ZoBio (Leiden, The Netherlands) and Domainex Ltd. (Cambridge, UK) announce a collaboration with FORMA Therapeutics (Watertown, MA, USA) to provide NMR-based structural biology services for a substantial panel of FORMA drug targets.
The goal of the collaboration is to use ZoBio’s expertise in protein nuclear magnetic resonance (NMR) to elucidate the molecular basis for compound-target interaction, to complement ongoing X-ray crystallography approaches. NMR is currently the only alternative to crystallography capable of elucidating atomic resolution, 3D structural information. Under the agreement, ZoBio will design and express protein variants suitable for structural studies, to support FORMA’s oncology drug discovery research. In addition, Domainex will apply its Combinatorial Domain Hunting technology to...
This award is recognition of both Pierre Fabre's expertise in dermatology, one of its development priorities, and of its ability to form public-private partnerships, such as that established with the University of Bordeaux
Recognition for major progress
Each year, the Prix Galien award distinguishes recent therapeutic innovations, made available to the public. It is conferred after an evaluation by an independent panel of experts and eminent specialists. Its renown and prestige have made it the highest distinction in the field. Pierre Fabre Dermatologie, a subsidiary of Pierre Fabre Dermo-Cosmetics, was distinguished today by the Prix Galien award (France) for Hemangiol®, an oral pediatric propranolol solution specifically developed for some severe infantile hemangiomas. Hemangiol® was successively approved...
Precisely engineered cell line will facilitate a new revenue stream and enable faster, more efficient production of therapeutic antibodies
Horizon Discovery Group plc (LSE:HZD) (Horizon), a leading provider of research tools to support translational genomics and the development of personalized medicines, today announced that its Bioproduction division has shipped its first commercially available engineered CHO cell line for use in manufacturing of therapeutic antibodies. Horizon’s innovative licensing model brings these cutting edge bioproduction cells within reach of...
Team identifies ‘markers’ to spot old cells in the body – offering hope in the fight against cancer and ageing
A new advance in biomedical research at the University of Leicester could have potential in the future to assist with tackling diseases and conditions associated with ageing – as well as in treating cancer. The research, which has shown promise in clinical samples, has been published in the prestigious scientific journal, Cell Death and Disease. The group of scientists coordinated by Dr Salvador Macip from the Mechanisms of Cancer and Ageing Lab and...
Unique disease outbreaks across the globe are escalating the demand for screening and spurring the infectious disease diagnostic market. The market will continue to develop as unmet technological needs lead to the creation of faster, more capable platforms. Molecular diagnostics is growing the fastest among the infectious disease market segments, clocking a compound annual growth of 15.30 percent. Although these...
Set up by the Prime Minister, Jim O’Neill and his colleagues were tasked with looking at the economic and societal costs of antibiotic resistance. The figures published today by the O’Neill commission make sobering reading. They estimate by 2050 there will be 10 million deaths a year from antibiotic resistant infections at a cost of up to $100 trillion. Professor Garner said ‘the O’Neill commission’s first report highlights just how...
Users of the SPARC technology at Chalmers University of Technology in Gothenburg, Sweden are applying cathodoluminescence measurements to study the properties of nanophotonic devices. Dr Ruggero Verre is a post-doctoral researcher in the Department of Applied Physics - Division of Bionanophotonics at the Chalmers University of Technology in Gothenburg in southern Sweden. His work in the group headed by...
This 24-month project, funded from the European Union Seventh Framework Programme (FP7-SME-2013), will incorporate a contactless sample transportation system for histology. Histology, the microscopic examination of cell tissue samples, is an essential component in the early detection of diseases such as cancer. Total pathology services, of which histology is an important part, costs the UK’s NHS an estimated £2.5 billion...
Time is often spent manually tightening connections between columns using a handheld tool – time which could otherwise be spent analyzing results or running more investigations. Preventing GC leaks has become a priority for researchers looking to save time and money while achieving high quality results. GC column connections leak because capillary column ferrules made of graphite polyimide blends loosen after...
The maximum funding available this year for each grant is $10,000 and is awarded to the science departments of colleges with less than 5,000 full-time students for the purchase of scientific equipment, audio-visual or other teaching aids, and/or library materials for use in the teaching of science at the undergraduate level. This year’s awardees are as follows...
Held in the auspicious setting of The Grocers’ Hall in the City of London on 5 December 2014, the day-long free symposium was opened by Dr Dominic Harrington, Scientific Director at Viapath, who spoke of the unprecedented opportunity that the Innovation Academy offered to the profession to share ideas around the founding principles of Innovation, Quality and Staff Development and ultimately improve the lives of patients...
Product design and development firm Cambridge Consultants is working with non-profit enterprise Diagnostics For All to develop a low-cost point-of-care device for testing patients for the Ebola virus. The project is being funded with a $1m challenge grant from Massachusetts Life Sciences Center, which supports innovation-driven economic development initiatives. The goal of the project is to develop a device – within months rather than...
In separate presentations he will discuss the ‘Applications of Dynamic Light Scattering as PAT for on-line nano-particle characterization’ and ‘In-situ monitoring of high shear and fluid bed processing using spatial filter velocimetry’. Both address areas of growing emphasis in pharmaceutical production. The continuing importance of large molecule based therapeutics, and the drive to reduce the particulate size of small molecule APIs, is bringing new challenges for...
The new products comprise 3 different monoclonal antibodies to the Ebola virus and 2 recombinant proteins (from the Sudan and Zaire strains) suitable for use in producing an optimised ELISA test kit for Ebola. An antigen-capture enzyme-linked immunosorbant assay (ELISA) test for Ebola offers the possibility of diagnosis within the first few days after symptoms begin. Ebola, also known as Ebola hemorrhagic fever, is a disease that typically...
This rapid test is designed to be run on Ubiquitome’s hand-held, battery powered real-time PCR device, the Freedom4. IDT, a market leader in the manufacture of GMP quality products for use in molecular diagnostic tests, is leveraging its PrimeTime qPCR Assay platform to develop an assay that will provide accurate and consistent test results for Ebola virus disease. Fitting in the palm of a hand, Ubiquitome’s Freedom4...
Dr. David Clemmons, co-inventor of the technology and a highly reputable key opinion leader in endocrinology and metabolism, will collaborate on the drug optimization and development programs. Alizé Pharma III SAS, an Alizé Pharma group company specialized in the development of biopharmaceuticals to treat metabolic disorders and rare diseases, today announces that it has acquired exclusive worldwide rights to...
This document provides recommendations for cytology laboratories to use in developing preexamination, examination, and postexamination processes and procedures for nongynecological cytology specimen management. All specimens sent for nongynecological cytology evaluation should be collected and prepared using techniques that produce slide preparations that improve patients’ medical care by enhancing diagnostic accuracy in a cost-effective manner. This edition...
The Zetasizer APS automated plate sampling system is supporting the systematic study of the aggregation behavior of proteins, a fundamental component of the services provided by SARomics Biostructures. The company, which is based in Lund, Sweden within the biotech cluster of the Medicon Valley, is a research-intensive organization with clients around the world. The Zetasizer APS is a robust, simple-to-operate system that uses laser light scattering to determine a number of parameters associated...
The two documents are now available to download from the company’s website. The first one is an application sheet which gives useful information as per how to arrest this annual outbreak. The second one is an educational infographic with facts about the virus, its impact and the ways to tackle it. Norovirus, or the diarrhoea and vomiting (D&V) bug, is a highly contagious winter scourge for which there is no treatment...
The vaccine was developed by the Austrian biotech company AFFiRiS AG and targets a protein called alpha-Synuclein. The protein plays a key role in the onset and progression of Parkinson's as well as multiple system atrophy (MSA), an orphan disease. This vaccine has the potential to modify disease progression, rather than only symptomatic improvements available with current treatment strategies. The start of the...
Recognition for major progress
Horizon Discovery Group plc (LSE:HZD) (Horizon), a leading provider of research tools to support translational genomics and the development of personalized medicines, today announced that its Bioproduction division has shipped its first commercially available engineered CHO cell line for use in manufacturing of therapeutic antibodies. Horizon’s innovative licensing model brings these cutting edge bioproduction cells within reach of...
A new advance in biomedical research at the University of Leicester could have potential in the future to assist with tackling diseases and conditions associated with ageing – as well as in treating cancer. The research, which has shown promise in clinical samples, has been published in the prestigious scientific journal, Cell Death and Disease. The group of scientists coordinated by Dr Salvador Macip from the Mechanisms of Cancer and Ageing Lab and...